These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16886918)

  • 1. Clinical features of Japanese male patients with type 1 autoimmune hepatitis.
    Miyake Y; Iwasaki Y; Sakaguchi K; Shiratori Y
    Aliment Pharmacol Ther; 2006 Aug; 24(3):519-23. PubMed ID: 16886918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune hepatitis with acute presentation in Japan.
    Miyake Y; Iwasaki Y; Kobashi H; Yasunaka T; Ikeda F; Takaki A; Yamamoto K
    Dig Liver Dis; 2010 Jan; 42(1):51-4. PubMed ID: 19473895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of autoimmune hepatitis diagnosed based on simplified criteria of the International Autoimmune Hepatitis Group.
    Miyake Y; Iwasaki Y; Kobashi H; Yasunaka T; Ikeda F; Takaki A; Yamamoto K
    Dig Liver Dis; 2010 Mar; 42(3):210-5. PubMed ID: 19632907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features of type 1 autoimmune hepatitis in elderly Italian patients.
    Granito A; Muratori L; Pappas G; Muratori P; Ferri S; Cassani F; Lenzi M; Bianchi FB
    Aliment Pharmacol Ther; 2005 May; 21(10):1273-7. PubMed ID: 15882249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group criteria in acute-onset autoimmune hepatitis.
    Fujiwara K; Yasui S; Tawada A; Fukuda Y; Nakano M; Yokosuka O
    Liver Int; 2011 Aug; 31(7):1013-20. PubMed ID: 21733091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis.
    Miyake Y; Iwasaki Y; Terada R; Takagi S; Okamaoto R; Ikeda H; Sakai N; Makino Y; Kobashi H; Takaguchi K; Sakaguchi K; Shiratori Y
    J Hepatol; 2005 Dec; 43(6):951-7. PubMed ID: 16143423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis: effect of age, gender, and genetic background.
    Bittencourt PL; Farias AQ; Porta G; Cançado EL; Miura I; Pugliese R; Kalil J; Goldberg AC; Carrilho FJ
    J Clin Gastroenterol; 2008 Mar; 42(3):300-5. PubMed ID: 18223493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applicability of the IAIHG scoring system to the diagnosis of antimitochondrial/anti-M2 seropositive variant form of autoimmune hepatitis.
    Farias AQ; Gonçalves LL; Bittencourt PL; De Melo ES; Abrantes-Lemos CP; Porta G; Nakhle MC; Carrilho FJ; Cancado EL
    J Gastroenterol Hepatol; 2006 May; 21(5):887-93. PubMed ID: 16704541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of autoimmune hepatitis at age 65 and older.
    Verslype C; George C; Buchel E; Nevens F; van Steenbergen W; Fevery J
    Aliment Pharmacol Ther; 2005 Mar; 21(6):695-9. PubMed ID: 15771755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis.
    Czaja AJ; Cassani F; Cataleta M; Valentini P; Bianchi FB
    Hepatology; 1996 Nov; 24(5):1068-73. PubMed ID: 8903377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitis.
    Mehendiratta V; Mitroo P; Bombonati A; Navarro VJ; Rossi S; Rubin R; Herrine SK
    Clin Gastroenterol Hepatol; 2009 Jan; 7(1):98-103. PubMed ID: 18955163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse.
    Montano-Loza AJ; Carpenter HA; Czaja AJ
    Am J Gastroenterol; 2007 May; 102(5):1005-12. PubMed ID: 17319926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum BAFF levels in patients with autoimmune hepatitis.
    Migita K; Abiru S; Maeda Y; Nakamura M; Komori A; Ito M; Fujiwara S; Yano K; Yatsuhashi H; Eguchi K; Ishibashi H
    Hum Immunol; 2007 Jul; 68(7):586-91. PubMed ID: 17584580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis.
    Czaja AJ; Donaldson PT; Lohse AW
    Am J Gastroenterol; 2002 Feb; 97(2):413-9. PubMed ID: 11866281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and HLA phenotypes of type 1 autoimmune hepatitis in North American patients outside DR3 and DR4.
    Czaja AJ; Carpenter HA; Moore SB
    Liver Int; 2006 Jun; 26(5):552-8. PubMed ID: 16761999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune hepatitis in children: what is different from adult AIH?
    Mieli-Vergani G; Vergani D
    Semin Liver Dis; 2009 Aug; 29(3):297-306. PubMed ID: 19676002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune hepatitis with incidental histologic features of bile duct injury.
    Czaja AJ; Carpenter HA
    Hepatology; 2001 Oct; 34(4 Pt 1):659-65. PubMed ID: 11584360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology.
    Czaja AJ; Davis GL; Ludwig J; Baggenstoss AH; Taswell HF
    Gastroenterology; 1983 Sep; 85(3):713-7. PubMed ID: 6192038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic features of the severe form of acute type 1 autoimmune hepatitis.
    Abe M; Onji M; Kawai-Ninomiya K; Michitaka K; Matsuura B; Hiasa Y; Horiike N
    Clin Gastroenterol Hepatol; 2007 Feb; 5(2):255-8. PubMed ID: 17218164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autoimmune hepatitis].
    Ostojić R
    Acta Med Croatica; 2003; 57(3):201-5. PubMed ID: 14582466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.